PortfoliosLab logoPortfoliosLab logo
AMT vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMT vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Tower Corporation (AMT) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMT achieves a 2.46% return, which is significantly lower than NVS's 11.31% return. Over the past 10 years, AMT has underperformed NVS with an annualized return of 7.71%, while NVS has yielded a comparatively higher 10.78% annualized return.


AMT

1D
0.22%
1M
-3.12%
YTD
2.46%
6M
5.28%
1Y
-15.74%
3Y*
1.76%
5Y*
-4.83%
10Y*
7.71%

NVS

1D
1.26%
1M
-2.03%
YTD
11.31%
6M
12.12%
1Y
32.56%
3Y*
17.94%
5Y*
14.22%
10Y*
10.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMT vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMT
American Tower Corporation
2.46%-0.92%-12.16%5.37%-25.67%32.89%-0.48%47.87%13.32%37.71%
NVS
Novartis AG
11.31%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%

Correlation

The correlation between AMT and NVS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jun 5, 1998

0.25

Fundamentals

Market Cap

AMT:

$82.36B

NVS:

$285.35B

EPS

AMT:

$6.14

NVS:

$6.99

PE Ratio

AMT:

28.71

NVS:

21.31

PEG Ratio

AMT:

8.19

NVS:

1.44

PS Ratio

AMT:

7.64

NVS:

5.14

PB Ratio

AMT:

22.55

NVS:

7.41

Total Revenue (TTM)

AMT:

$10.82B

NVS:

$56.05B

Gross Profit (TTM)

AMT:

$7.94B

NVS:

$42.19B

EBITDA (TTM)

AMT:

$6.71B

NVS:

$22.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMT vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMT
AMT Risk / Return Rank: 1818
Overall Rank
AMT Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
AMT Sortino Ratio Rank: 1515
Sortino Ratio Rank
AMT Omega Ratio Rank: 1616
Omega Ratio Rank
AMT Calmar Ratio Rank: 2020
Calmar Ratio Rank
AMT Martin Ratio Rank: 2525
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 8080
Overall Rank
NVS Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 7979
Sortino Ratio Rank
NVS Omega Ratio Rank: 7777
Omega Ratio Rank
NVS Calmar Ratio Rank: 8181
Calmar Ratio Rank
NVS Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMT vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for American Tower Corporation (AMT) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMTNVSDifference
Sharpe ratioReturn per unit of total volatility

-2.20

Sortino ratioReturn per unit of downside risk

-2.99

Omega ratioGain probability vs. loss probability

0.91

1.27

-0.36

Calmar ratioReturn relative to maximum drawdown

-0.59

2.59

-3.18

Martin ratioReturn relative to average drawdown

-0.85

6.11

-6.96

AMT vs. NVS - Sharpe Ratio Comparison

The current AMT Sharpe Ratio is -0.65, which is lower than the NVS Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of AMT and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMT vs. NVS - Drawdown Comparison

The maximum AMT drawdown since its inception was -98.70%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for AMT and NVS.


Loading charts...

Drawdown Indicators


AMTNVSDifference

Max Drawdown

Largest peak-to-trough decline

-98.70%

-42.10%

-56.60%

Max Drawdown (1Y)

Largest decline over 1 year

-26.67%

-12.65%

-14.02%

Max Drawdown (3Y)

Largest decline over 3 years

-27.54%

-19.95%

-7.59%

Max Drawdown (5Y)

Largest decline over 5 years

-45.34%

-20.42%

-24.92%

Max Drawdown (10Y)

Largest decline over 10 years

-45.34%

-26.03%

-19.31%

Current Drawdown

Current decline from peak

-32.06%

-8.99%

-23.07%

Average Drawdown

Average peak-to-trough decline

-27.02%

-10.92%

-16.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.60%

5.34%

+13.26%

Volatility

AMT vs. NVS - Volatility Comparison

American Tower Corporation (AMT) has a higher volatility of 8.42% compared to Novartis AG (NVS) at 7.67%. This indicates that AMT's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMTNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.42%

7.67%

+0.75%

Volatility (6M)

Calculated over the trailing 6-month period

19.69%

15.16%

+4.53%

Volatility (1Y)

Calculated over the trailing 1-year period

24.43%

21.05%

+3.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.43%

18.94%

+7.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.23%

19.66%

+6.57%

Dividends

AMT vs. NVS - Dividend Comparison

AMT's dividend yield for the trailing twelve months is around 3.96%, more than NVS's 3.20% yield.


PositionTTM20252024202320222021202020192018201720162015
AMT
American Tower Corporation
3.96%3.87%3.53%2.99%2.77%1.78%2.02%1.64%1.99%1.84%2.05%1.87%
NVS
Novartis AG
3.20%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

AMT vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between American Tower Corporation and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20222023202420252026
2.74B
13.52B
(AMT) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

AMT vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between American Tower Corporation and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

68.0%70.0%72.0%74.0%76.0%78.0%20222023202420252026
73.9%
74.4%
Portfolio components
AMT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, American Tower Corporation reported a gross profit of 2.02B and revenue of 2.74B. Therefore, the gross margin over that period was 73.9%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

AMT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, American Tower Corporation reported an operating income of 1.16B and revenue of 2.74B, resulting in an operating margin of 42.4%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

AMT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, American Tower Corporation reported a net income of 836.80M and revenue of 2.74B, resulting in a net margin of 30.6%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.


Frequently Asked Questions


AMT and NVS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMT has higher volatility (8.42%) compared to NVS (7.67%). In terms of maximum drawdown, AMT dropped -98.70% vs NVS's -42.10%.

NVS currently has the higher Sharpe Ratio (1.56 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMT and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer